Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

Filter your results:

Types

Topics

3 Results Found

Advisory
Member

FDA Rescinds the Laboratory Developed Test Final Regulation

Advisory
The AHA appreciates that the FDA and the federal district court have acknowledged the unique value and safety of laboratory tests developed by hospitals and health systems for direct use in patient care.
Laboratory Developed Tests (LDTs), Regulatory Relief, Regulations and Regulatory Advocacy
Letter/Comment
Public

AHA Comments on HHS RFI on MAHA Initiative

Letter/Comment
AHA comments on the U.S. Department of Health and Human Services request for information to ensure lawful regulation and unleash innovation to promote better health.
Innovation, Regulations and Regulatory Advocacy
Advisory
Member

Home Health Prospective Payment System Proposed Rule for CY 2026

Advisory
The Centers for Medicare & Medicaid Services (CMS) June 30 issued its proposed rule for the calendar year (CY) 2026 home health (HH) prospective payment system (PPS). Comments are due Sept. 2, and a final rule is expected around Nov. 1. New policies would generally be effective Jan. 1, 2026.
Home Health PPS, Home Health, Regulations and Regulatory Advocacy